Senior Product Manager, Patient Marketing

Waltham, MA (Hybrid)

$147K/yr – $196K/yrSenior Level5+ years expFull time

Posted 5 hrs ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Own the US marketing vision and multi-channel execution, leading cross-functional programs from patient initiatives to agency management and budget stewardship.

  • Lead multi-year strategy, stakeholder engagement, and budget development
  • Develop and execute measurement plans and field strategies with sales, training, and patient services

Job Description

Responsibilities

  • Lead the development of personal and non-personal tactics, including but not limited to patient programs, co-development of content with patient ambassadors, live events on social media, social media content, digital assets, media planning and print.
  • Playing a key role in driving US Brand Planning – inclusive of defining stakeholder strategies - and budget development
  • Helping define and execute the vision and plan for US marketing. Manage multiple agencies in the execution of that plan.
  • Developing field execution strategy for patient-facing initiatives in partnership with training and sales leadership and patient services leadership
  • Developing a multi-channel/digital strategy and measurement plan
  • Develop the overall tactical measurement plan and develop courses of action based on these metrics
  • Supporting POA strategy and execution
  • Efficiently and thoughtfully administering the US marketing budget
  • Working closely with regulatory, legal, and compliance

Requirements

  • Bachelor's degree required
  • 5+ years of biotech/pharma marketing experience
  • Eye care experience a plus
  • Experience in sales or customer-facing roles
  • Willing to travel domestically up to 30% of the time and attend events outside of business hours (e.g., occasional weekends and evenings)
  • Proficiency or comfort with high science data and demonstrated ability to convert into promotional messaging
  • Ability to navigate and be successful in a fast-paced, results-driven environment, managing through ambiguity
  • Commitment to collaboration and engagement, with a history of success leading in a matrix environment and with agency partners
  • An entrepreneurial spirit coupled with the drive to embrace innovation and develop creative but well-reasoned solutions to business challenges
  • Demonstrated integrity on the job, including an understanding of relevant rules and regulations

Benefits

  • 401(k) plan with company match
  • inclusive family building benefits
  • flexible time off
  • summer and winter shutdowns
  • paid family leave
  • disability and life insurance
  • and more
Apellis Pharmaceuticals logo

Apellis Pharmaceuticals

3.2 Glassdoor

At Apellis, we are committed to developing transformative therapies for people living with a broad range of debilitating diseases by controlling complement, part of the body’s immune system. Our work is rooted centrally at C3, which is the only target in the complement cascade that addresses all three pathways that can drive disease. Targeting C3 has broad platform potential to treat many diseases where patients have few or no treatment options available. Our programs across ophthalmology, nephrology, hematology, and neurology are further exploring what is possible by targeting C3. You can view our community guidelines here: Community guidelines: http://bit.ly/476Q8

Founded in 2008
Waltham, Massachusetts, USA
796 employees (44 in marketing)
59% recommend to a friend
71% CEO approval

Traffic Signals

Monthly Visitors
27.9K
Traffic Source Mix
Search
41.6%
Direct
46.1%
Referral
6.4%
Social
4.5%
Paid
1.3%

Headcount Trend

Current headcount: ~810

Marketing Team

Marketing Team Size
39 (5% of company)
Median Tenure
3 years
Marketing Roles Posted (Last 30 Days)
1

Funding

Total Funding
$919.6M
Last Raise
$275M
Post IPO Debt, 10 months ago

Funding History

  • Jun 2025
    Post IPO Debt • $275M
  • May 2024
    Post IPO Debt • $475M
  • Apr 2022
    Post IPO Equity • $1.1M

Recent News